학술논문
Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial
Document Type
Article
Author
Smith, Matthew ; Parker, Chris; Saad, Fred; Miller, Kurt; Tombal, Bertrand; Ng, Quan Sing; Boegemann, Martin; Matveev, Vsevolod; Piulats, Josep Maria; Zucca, Luis Eduardo; Karyakin, Oleg; Kimura, Go; Matsubara, Nobuaki; Nahas, William Carlos; Nolè, Franco; Rosenbaum, Eli; Heidenreich, Axel; Kakehi, Yoshiyuki; Zhang, Amily; Krissel, Heiko; Teufel, Michael; Shen, Junwu; Wagner, Volker; Higano, Celestia
Source
In The Lancet Oncology March 2019 20(3):408-419
Subject
Language
ISSN
1470-2045